Search

Your search keyword '"Damond, Florence"' showing total 458 results

Search Constraints

Start Over You searched for: Author "Damond, Florence" Remove constraint Author: "Damond, Florence"
458 results on '"Damond, Florence"'

Search Results

2. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

4. Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results.

6. Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo

7. A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors : A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain

8. First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection : A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)

10. Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection.

14. Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa

21. Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2—Infected Patients: The ACHI E V 2E Collaboration Study Group

22. Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage

25. Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection

26. High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort

31. In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions

32. Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’

37. Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era

38. Rilpivirine in HIV-1-positive women initiating pregnancy

39. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test

40. Evaluation of the Roche Cobas TaqMan and Abbott realtime extraction-quantification system for HIV-1 subtypes

41. High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort

42. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives

44. Plasma RNA Quantification and HIV-1 Divergent Strains

Catalog

Books, media, physical & digital resources